Genetic risk factor for Crohn’s disease influences natural microbiome changes during pregnancy – new publication by miTarget scientists View article (external site) Additional Details Contacts: Prof. Dr. med. Philip Rosenstiel Principle Investigator, Platform leader Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) p.rosenstiel@mucosa.de P3 (Phase 1),P3 (Phase 2) Dr. rer. nat. Víctor López-Agudelo Associated Scientist Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) v.lopez-agudelo@ikmb.uni-kiel.de P3 (Phase 1),P3 (Phase 2) Dr. rer. nat. Maren Falk-Paulsen Associated Scientist Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) m.paulsen@ikmb.uni-kiel.de P3 (Phase 1),P3 (Phase 2) Dr. rer. nat. Felix Sommer Principle Investigator Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) f.sommer@ikmb.uni-kiel.de P5 (Phase 1),P4 (Phase 2) Prof. Dr. rer. nat. David Ellinghaus Principle Investigator Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) d.ellinghaus@ikmb.uni-kiel.de INF (Phase 1),INF (Phase 2) Eike Matthias Wacker Doctoral Researcher Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) e.wacker@ikmb.uni-kiel.de INF (Phase 1),INF (Phase 2)
Prof. Dr. med. Philip Rosenstiel Principle Investigator, Platform leader Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) p.rosenstiel@mucosa.de P3 (Phase 1),P3 (Phase 2)
Dr. rer. nat. Víctor López-Agudelo Associated Scientist Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) v.lopez-agudelo@ikmb.uni-kiel.de P3 (Phase 1),P3 (Phase 2)
Dr. rer. nat. Maren Falk-Paulsen Associated Scientist Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) m.paulsen@ikmb.uni-kiel.de P3 (Phase 1),P3 (Phase 2)
Dr. rer. nat. Felix Sommer Principle Investigator Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) f.sommer@ikmb.uni-kiel.de P5 (Phase 1),P4 (Phase 2)
Prof. Dr. rer. nat. David Ellinghaus Principle Investigator Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) d.ellinghaus@ikmb.uni-kiel.de INF (Phase 1),INF (Phase 2)
Eike Matthias Wacker Doctoral Researcher Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) e.wacker@ikmb.uni-kiel.de INF (Phase 1),INF (Phase 2)